個人化糖尿病日常飲食方案生成工具

首頁

AI 提示詞列表

醫療健康

糖尿病日常飲食方案制定

${:__('collect %s',糖尿病日常飲食方案制定)}$

醫療健康

依據使用者的年齡、身高體重、日常活動量和血糖控制情況，生成適合的每日飲食方案，幫助使用者穩定控制血糖。

提示內容

複製

Based on the user's provided age, height and weight, daily activity intensity, and recent blood sugar control status, combined with glucose control requirements in the Chinese Dietary Guidelines, generate a daily diet plan that fits the user's eating habits, explain the general arrangement of three main meals and snacks, list suitable common ingredients and reference intakes, avoid food combinations that cause large blood sugar fluctuations, and express all content in plain, easy-to-understand language that ordinary people can understand without using overly professional medical terms.

複製

依據使用者提供的年齡、身高體重、每日活動強度和近期血糖控制狀況，結合中國居民膳食指南的控糖要求，生成符合使用者飲食習慣的每日日常飲食方案，說明三餐和加餐的大致安排，列出適宜選擇的常見食材和參考攝取量，避開容易引起血糖大幅波動的飲食搭配，全部內容用淺顯易懂、一般人能看懂的語言表述，不使用過於專業的醫學術語。

複製

分享點擊複製鏈接

評論 (0)

0/300

提交

推薦

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists, focusing on drug-drug interactions, contraindications, and dosage appropriateness. Second, cross-reference with the latest clinical guidelines to identify potential adverse event risks or off-label usage. Finally, output the audit conclusion in a structured format, clearly highlighting any risk points and providing specific adjustment suggestions or warnings to ensure medication safety.

處方審核助手

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, dosage appropriateness, and allergy contraindications, identifying potential risks, and providing adjustment suggestions to ensure the treatment plan aligns with the latest clinical guidelines.

處方審核助手

Act as an intelligent audit assistant for a hospital pharmacy. Perform a deep compliance check on the provided electronic prescription data. First, extract patient demographics, diagnosis, and the list of prescribed medications, focusing on analyzing potential drug-drug interactions, especially for elderly patients or those with hepatic/renal impairment. Second, cross-reference medication contraindications with the patient's medical history and allergies, and identify any off-label usage. Finally, generate a structured audit report that clearly highlights potential risks, recommends safe alternative options or dosage adjustments, and flags items requiring manual pharmacist review, ensuring the prescription adheres to clinical medication guidelines before dispensing.

處方審核助手

Act as a senior clinical pharmacist to review the provided electronic prescription for compliance. Focus on analyzing the patient's current medication list for potential drug interactions, contraindication conflicts, or dosages exceeding recommended ranges. If risks are identified, point out specific issues based on the latest clinical guidelines and provide adjustment suggestions; if no anomalies exist, confirm that the prescription meets standard treatment protocols.

處方審核助手

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Valsartan 80mg once daily, and Ibuprofen 400mg three times daily for joint pain. Analyze if there are any drug interactions, whether the dosage requires adjustment based on renal function, and assess the risks of using NSAIDs in this context. Provide specific adjustment suggestions or alternative solutions to ensure medication safety.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag potential risks and suggest adjustments, ensuring the treatment plan aligns with the latest clinical guidelines.